Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지

Antiviral Effect of Amphotericin B on Japanese Encephalitis Virus Replication

  • Kim, Hun (Department of Biotechnology, Yonsei University, Korea Food and Drug Administration) ;
  • Kim, Seong-Jun (Department of Biotechnology, Yonsei University) ;
  • Park, Sue-Nie (Korea Food and Drug Administration) ;
  • Oh, Jong-Won (Department of Biotechnology, Yonsei University)
  • Published : 2004.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

Amphotericin B (AmB), an amphipathic polyene macrolide, is an antifungal drug produced by Streptomyces nodosus. Recently, AmB has been shown to exert antiviral activity against rubella virus and human immunodeficiency virus by different mechanisms. In this study, we evaluated the antiviral effect of AmB against Japanese encephalitis virus (JEV) and investigated which step of the viral life cycle was inhibited by AmB to understand the mechanism of antiviral action of AmB. AmB reduced both plaque size and number in the infected cells in a dose-dependent manner. In addition, a 200-fold reduction of infectious virus titer was observed by treatment of infected cells with $5\mug/ml$ of AmB. AmB acted at the post virus-infection step, but not during adsorption of virus to host cells. Western blot analysis revealed that the accumulated level of JEV envelope protein dramatically decreased in the infected cells by treatment with $5-10\mug/ml$ of AmB. Our results indicate that AmB inhibits the replication of JEV at the postinfection step by interfering with viral replication and/or by inhibiting the synthesis of viral proteins.

Keywords

References

  1. Ablordeppey, S. Y., P. Fan, J. H. Ablordeppey, and L. Mardenborough. 1999. Systemic antifungal agents against AIDSrelated opportunistic infections: Current status and emerging drugs in development. Curr. Med. Chem. 6: 1151-1195
  2. Aloia, R. C., H. Tian, and F. C. Jensen. 1993. Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc. Natl. Acad. Sci. USA 90: 5181-5185
  3. Arroyo, J., F. Guirakhoo, S. Fenner, Z. X. Zhang, T. P. Monath, and T. J. Chambers. 2001. Molecular basis for attenuation of neurovirulence of a yellow fever virus/ Japanese encephalitis virus chimera vaccine (ChimeriVax- JE). J. Virol. 75: 934-942
  4. Baginski, M., H. Resat, and E. Borowski. 2002. Comparative molecular dynamics simulations of amphotericin B-cholesterol/ ergosterol membrane channels. Biochim. Biophys. Acta 1567: 63-78
  5. Bolard, J. 1986. How do the polyene macrolide antibiotics affect the cellular membrane properties? Biochim. Biophys. Acta 864: 257-304
  6. Chambers, T. J., C. S. Hahn, R. Galler, and C. M. Rice. 1990. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 44: 649-688
  7. Choi, W.-C., S.-Y. Hwang, T.-K. Park, and S.-K. Kim. 2002. Identification of Streptomyces sp. producing new polyene antibiotics and in vivo antimicrobial activity of tetrin C against phytopathogenic fungi. J. Microbiol. Biotechnol. 12: 204-208
  8. Fournier, I., J. Barwicz, and P. Tancrede. 1998. The structuring effects of amphotericin B on pure and ergosterolor cholesterol-containing dipalmitoylphosphatidylcholine bilayers: A differential scanning calorimetry study. Biochim. Biophys. Acta 1373: 76-86
  9. Igarashi, A. 1992. Epidemiology and control of Japanese encephalitis. World Health Stat. Q 45: 299-305
  10. Kerridge, D. 1986. Mode of action of clinically important antifungal drugs. Adv. Microb. Physiol. 27: 1-72
  11. Kessler, H. A., J. Dixon, C. R. Howard, K. Tsiquaye, and A. J. Zuckerman. 1981. Effects of amphotericin B on hepatitis B virus. Antimicrob. Agents Chemother. 20: 826-833
  12. Konopka, K., L. S. Guo, and N. Duzgunes. 1999. Anti-HIV activity of amphotericin B-cholesteryl sulfate colloidal dispersion in vitro. Antiviral Res. 42: 197-209
  13. Lee, C.-H., B.-J. Kim, G. J. Choi, K. Y. Cho, H. Yang, C. Shin, S. Min, and Y. Lim. 2002. Streptomyces with antifungal activity against rice blast causing fungus, Magnaporthe grisea. J. Microbiol. Biotechnol. 12: 1026-1028
  14. Pleskoff, O., M. Seman, and M. Alizon. 1995. Amphotericin B derivative blocks human immunodeficiency virus type 1 entry after CD4 binding: Effect on virus-cell fusion but not on cell-cell fusion. J. Virol. 69: 570-574
  15. Rice, C. M. 1996. Flaviviridae: the viruses and their replication, pp. 931-959. In B. N. Fields, D. M. Knipe, and P. M. Howley (eds.), Fields Virology, 3rd ed. Lippincott- Raven Publishers, Philadelphia, PA. U.S.A
  16. Schroter, M., B. Zollner, P. Schafer, R. Laufs, and H. H. Feucht. 2001. Quantitative detection of hepatitis C virus RNA by light cycler PCR and comparison with two different PCR assays. J. Clin. Microbiol. 39: 765-768
  17. Su, H. L., C. L. Liao, and Y. L. Lin. 2002. Japanese encephalitis virus infection initiates endoplasmic reticulum stress and an unfolded protein response. J. Virol. 76: 4162- 4171
  18. Trajkovic, V., M. Markovic, T. Samardzic, D. J. Miljkovic, D. Popadic, and M. M. Stojkovic. 2001. Amphotericin B potentiates the activation of inducible nitric oxide synthase and causes nitric oxide-dependent mitochondrial dysfunction in cytokine-treated rodent astrocytes. Glia 35: 180-188
  19. Umino, Y. and M. Tashiro. 2001. Inhibition of rubella virus growth by Fungizone. Vaccine 19: 1369-1372